PLoS ONE (Jan 2021)
Correction: Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0252041.].
PLoS ONE (Jan 2021)
[This corrects the article DOI: 10.1371/journal.pone.0252041.].